HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.

Abstract
Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive neurodegenerative disease caused by polyglutamine expansion within the Atrophin-1 protein. To study the mechanism of this disease and to test potential therapeutic methods, we established Atro-118Q transgenic mice, which express in neurons a mutant human Atrophin-1 protein that contains an expanded stretch of 118 glutamines. Consistent with the results from previous studies on transgenic mice that expressed mutant Atrophin-1 with 65 glutamines, Atro-118Q mice exhibited several neurodegenerative phenotypes that are commonly seen in DRPLA patients, including ataxia, tremors, and other motor defects. Overexpression of wild-type human Atrophin-1 could not rescue the motor and survival defects in Atro-118Q mice, indicating that the mutant protein with polyglutamine expansion does not simply function in a dominant negative manner. Biochemical analysis of Atro-118Q mice revealed hypoacetylation of histone H3 in brain tissues and thus suggested that global gene repression is an underlying mechanism for neurodegeneration in this mouse model. We further show that intraperitoneal administration of sodium butyrate, a histone deacetylase inhibitor, ameliorated the histone acetylation defects, significantly improved motor performance, and extended the average life span of Atro-118Q mice. These results support the hypothesis that transcription deregulation plays an important role in the pathogenesis of polyglutamine expansion diseases and suggest that reversion of transcription repression with small molecules such as sodium butyrate is a feasible approach to treating DRPLA symptoms.
AuthorsMingyao Ying, Rener Xu, Xiaohui Wu, Huaxing Zhu, Yuan Zhuang, Min Han, Tian Xu
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 18 Pg. 12580-6 (May 05 2006) ISSN: 0021-9258 [Print] United States
PMID16407196 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Butyrates
  • Histones
  • Isobutyrates
  • Nerve Tissue Proteins
  • Peptides
  • atrophin-1
  • polyglutamine
  • isobutyric acid
Topics
  • Acetylation
  • Animals
  • Brain (pathology)
  • Butyrates (pharmacology)
  • Disease Models, Animal
  • Histones (chemistry)
  • Humans
  • Isobutyrates
  • Mice
  • Mice, Transgenic
  • Myoclonic Epilepsies, Progressive (metabolism, pathology)
  • Nerve Tissue Proteins (genetics)
  • Neurodegenerative Diseases (pathology)
  • Peptides (chemistry)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: